189 related articles for article (PubMed ID: 34276822)
1. Small changes in the length of diselenide bond-containing linkages exert great influences on the antitumor activity of docetaxel homodimeric prodrug nanoassemblies.
Li L; Zuo S; Dong F; Liu T; Gao Y; Yang Y; Wang X; Sun J; Sun B; He Z
Asian J Pharm Sci; 2021 May; 16(3):337-349. PubMed ID: 34276822
[TBL] [Abstract][Full Text] [Related]
2. Probing the Superiority of Diselenium Bond on Docetaxel Dimeric Prodrug Nanoassemblies: Small Roles Taking Big Responsibilities.
Zuo S; Sun B; Yang Y; Zhou S; Zhang Y; Guo M; Sun M; Luo C; He Z; Sun J
Small; 2020 Nov; 16(45):e2005039. PubMed ID: 33078579
[TBL] [Abstract][Full Text] [Related]
3. Photosensitizer-driven nanoassemblies of homodimeric prodrug for self-enhancing activation and synergistic chemo-photodynamic therapy.
Zhang S; Wang Z; Kong Z; Wang Y; Zhang X; Sun B; Zhang H; Kan Q; He Z; Luo C; Sun J
Theranostics; 2021; 11(12):6019-6032. PubMed ID: 33897896
[TBL] [Abstract][Full Text] [Related]
4. Rational Engineering Docetaxel Prodrug Nanoassemblies: Response Modules Guiding Efficacy Enhancement and Toxicity Reduction.
Wang D; Li L; Xu H; Sun Y; Li W; Liu T; Li Y; Shi X; He Z; Zhai Y; Sun B; Sun J
Nano Lett; 2023 Apr; 23(8):3549-3557. PubMed ID: 37053460
[TBL] [Abstract][Full Text] [Related]
5. Probing the Role of Connecting Bonds and Modifying Chains in the Rational Design of Prodrug Nanoassemblies.
Wang D; Du C; Wang S; Li L; Liu T; Song J; He Z; Zhai Y; Sun B; Sun J
ACS Appl Mater Interfaces; 2022 Nov; 14(45):51200-51211. PubMed ID: 36397309
[TBL] [Abstract][Full Text] [Related]
6. Self-delivering prodrug-nanoassemblies fabricated by disulfide bond bridged oleate prodrug of docetaxel for breast cancer therapy.
Zhang S; Guan J; Sun M; Zhang D; Zhang H; Sun B; Guo W; Lin B; Wang Y; He Z; Luo C; Sun J
Drug Deliv; 2017 Nov; 24(1):1460-1469. PubMed ID: 28950729
[TBL] [Abstract][Full Text] [Related]
7. Redox-sensitive prodrug nanoassemblies based on linoleic acid-modified docetaxel to resist breast cancers.
Li M; Zhao L; Zhang T; Shu Y; He Z; Ma Y; Liu D; Wang Y
Acta Pharm Sin B; 2019 Mar; 9(2):421-432. PubMed ID: 30972286
[TBL] [Abstract][Full Text] [Related]
8. Probing the impact of sulfur/selenium/carbon linkages on prodrug nanoassemblies for cancer therapy.
Sun B; Luo C; Zhang X; Guo M; Sun M; Yu H; Chen Q; Yang W; Wang M; Zuo S; Chen P; Kan Q; Zhang H; Wang Y; He Z; Sun J
Nat Commun; 2019 Jul; 10(1):3211. PubMed ID: 31324811
[TBL] [Abstract][Full Text] [Related]
9. Trisulfide bond-mediated doxorubicin dimeric prodrug nanoassemblies with high drug loading, high self-assembly stability, and high tumor selectivity.
Yang Y; Sun B; Zuo S; Li X; Zhou S; Li L; Luo C; Liu H; Cheng M; Wang Y; Wang S; He Z; Sun J
Sci Adv; 2020 Nov; 6(45):. PubMed ID: 33148644
[TBL] [Abstract][Full Text] [Related]
10. Hybrid chalcogen bonds in prodrug nanoassemblies provides dual redox-responsivity in the tumor microenvironment.
Liu T; Li L; Wang S; Dong F; Zuo S; Song J; Wang X; Lu Q; Wang H; Zhang H; Cheng M; Liu X; He Z; Sun B; Sun J
Nat Commun; 2022 Nov; 13(1):7228. PubMed ID: 36434014
[TBL] [Abstract][Full Text] [Related]
11. Investigating the crucial roles of aliphatic tails in disulfide bond-linked docetaxel prodrug nanoassemblies.
Wang Y; Luo C; Zhou S; Wang X; Zhang X; Li S; Zhang S; Wang S; Sun B; He Z; Sun J
Asian J Pharm Sci; 2021 Sep; 16(5):643-652. PubMed ID: 34849169
[TBL] [Abstract][Full Text] [Related]
12. Minor Changes in Response Modules Leading to a "U-Shaped" Conversion Rate of Docetaxel Prodrug Nanoassemblies.
Li W; Wang D; Zhao H; Xu H; Li L; Huang Y; Shi X; Sun J; He Z; Sun B
Nano Lett; 2024 Jan; 24(1):394-401. PubMed ID: 38147432
[TBL] [Abstract][Full Text] [Related]
13. Reduction-Responsive Stearyl Alcohol-Cabazitaxel Prodrug Nanoassemblies for Cancer Chemotherapy.
Liu Y; Wang X; Wang Z; Liao R; Qiu Q; Wang Y; Luo C
Pharmaceutics; 2023 Jan; 15(1):. PubMed ID: 36678891
[TBL] [Abstract][Full Text] [Related]
14. Disulfide Bond-Driven Oxidation- and Reduction-Responsive Prodrug Nanoassemblies for Cancer Therapy.
Sun B; Luo C; Yu H; Zhang X; Chen Q; Yang W; Wang M; Kan Q; Zhang H; Wang Y; He Z; Sun J
Nano Lett; 2018 Jun; 18(6):3643-3650. PubMed ID: 29726685
[TBL] [Abstract][Full Text] [Related]
15. Precise engineering of disulfide bond-bridged prodrug nanoassemblies to balance antitumor efficacy and safety.
Sun Y; Wang S; Li Y; Wang D; Zhang Y; Zhang H; Lei H; Liu X; Sun J; Sun B; He Z
Acta Biomater; 2023 Feb; 157():417-427. PubMed ID: 36513247
[TBL] [Abstract][Full Text] [Related]
16. Redox-responsive nanoparticles based on Chondroitin Sulfate and Docetaxel prodrug for tumor targeted delivery of Docetaxel.
Li Y; Chen X; Ji J; Li L; Zhai G
Carbohydr Polym; 2021 Mar; 255():117393. PubMed ID: 33436222
[TBL] [Abstract][Full Text] [Related]
17. Critical roles of linker length in determining the chemical and self-assembly stability of SN38 homodimeric nanoprodrugs.
Wang X; Liu T; Huang Y; Dong F; Li L; Song J; Zuo S; Zhu Z; Kamei KI; He Z; Sun B; Sun J
Nanoscale Horiz; 2023 Jan; 8(2):235-244. PubMed ID: 36537183
[TBL] [Abstract][Full Text] [Related]
18. In vivo tailor-made protein corona of a prodrug-based nanoassembly fabricated by redox dual-sensitive paclitaxel prodrug for the superselective treatment of breast cancer.
Zhang D; Yang J; Guan J; Yang B; Zhang S; Sun M; Yang R; Zhang T; Zhang R; Kan Q; Zhang H; He Z; Shang L; Sun J
Biomater Sci; 2018 Aug; 6(9):2360-2374. PubMed ID: 30019051
[TBL] [Abstract][Full Text] [Related]
19. The effect of lengths of branched-chain fatty alcohols on the efficacy and safety of docetaxel-prodrug nanoassemblies.
Wang S; Liu T; Huang Y; Du C; Wang D; Wang X; Lv Q; He Z; Zhai Y; Sun B; Sun J
Acta Pharm Sin B; 2024 Mar; 14(3):1400-1411. PubMed ID: 38486988
[TBL] [Abstract][Full Text] [Related]
20. Impact of the amount of PEG on prodrug nanoassemblies for efficient cancer therapy.
Li Y; Li L; Jin Q; Liu T; Sun J; Wang Y; Yang Z; He Z; Sun B
Asian J Pharm Sci; 2022 Mar; 17(2):241-252. PubMed ID: 35582643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
